Want to join the conversation?
$AMGN and Servier announced the omecamtiv mecarbil Phase 3 development program will move forward in collaboration with Cytokinetics. Servier will make a $10MM option exercise payment, as well as future milestone and royalty payments, to $AMGN. Servier will assume a share of the development costs.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.